IBRX

IMMUNITYBIO INC

IBRX·45256X103·US·Common Stock·Healthcare - Biotechnology-Activist

IBRX (IMMUNITYBIO INC) is held by 163 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($298.4M), STATE STREET CORP ($187.3M), VANGUARD PORTFOLIO MANAGEMENT LLC ($156.4M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 100 funds bought IBRX.

163
Holders
(13 Elite)
$1.6B
Total Value
61% (163)
Consensus
100 buying - 63 selling
13F: Insider & Congress: Updated regularly
IBRX

Smart Money Verdict

View all
Loading verdict
Held by 163 funds
13 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Oct 6, 2026 · Activists Aug 6, 2026 · Congress Oct 12, 2026

InsiderSJSimon Barry J.Sell $269KOct 5, 2026
InsiderCCCohen CherylExercise 56K shOct 2, 2026
InsiderCCCohen CherylSell $851KOct 2, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
34.1M(+29.4%)$298.4M0.0%+128.37%
39
Increased
21.4M(+20.8%)$187.3M0.0%+112.84%
36
Increased
17.9M(+9.4%)$156.4M0.0%+28.81%
33
Increased
15.7M(+3.7%)$137.4M0.0%+29.72%
31
Decreased
11.6M(-8.1%)$101.1M0.0%+30.38%
0
Increased
11.1M(+153.0%)$97.2M0.1%+61.44%
48
Increased
9.8M(+22.6%)$86.2M0.0%+48.21%
36
Increased
5.6M(+292.9%)$48.9M0.0%+19.55%
47
Increased
3.6M(+42.3%)$31.2M0.0%+31.50%
39
Decreased
3.4M(-14.6%)$30.1M0.0%+263.56%
0
Decreased
3.2M(-0.1%)$28.3M0.0%+330.76%
0
Increased
3.2M(+8.5%)$28M0.0%+110.04%
31
Increased
2.9M(+16.6%)$25.3M0.0%+49.20%
33
Decreased
2.5M(-27.5%)$21.9M0.1%+252.41%
0
Increased
2.4M(+13.6%)$21.1M0.0%+28.20%
32
Decreased
2.2M(-10.8%)$19.1M0.0%+282.04%
0
Decreased
1.7M(-41.2%)$15.1M0.1%+30.38%
0
Increased
1.7M(+23.6%)$15M0.0%+26.96%
34
Increased
1.5M(+3.8%)$13.5M0.0%+34.16%
29
Decreased
1.5M(-2.6%)$12.9M0.0%+137.64%
0

Showing 1-20 of 172

1 / 9
IBRXIBRXIMMUNITYBIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used